» Authors » Steven H Itzkowitz

Steven H Itzkowitz

Explore the profile of Steven H Itzkowitz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 107
Citations 5104
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoon J, Shah S, Lin J, Kim M, Itzkowitz S, Wang C
Lancet Reg Health Am . 2024 Dec; 41:100954. PMID: 39650260
Asian Americans remain the fastest-growing racial group in the United States, and are anticipated to double over the next few decades. Asian Americans are the only major racial-ethnic group for...
2.
Savage L, Soto-Cossio L, Minardi F, Beyrouty M, Schoonover J, Musella J, et al.
JMIR Form Res . 2024 Sep; 8:e53224. PMID: 39321451
Background: Federally Qualified Health Centers (FQHCs) are an essential place for historically underserved patients to access health care, including screening for colorectal cancer (CRC), one of the leading causes of...
3.
Wang C, McKinley M, Vu A, Yang J, Gupta S, Gomez S, et al.
Gastro Hep Adv . 2024 Aug; 3(4):482-490. PMID: 39131721
Background And Aims: Gastrointestinal cancer incidence varies by race and ethnicity. In the United States (US), there are screening guidelines for esophageal cancer (EC) and colorectal cancer (CRC), but not...
4.
Kisiel J, Itzkowitz S, Ozbay A, Saoud L, Parton M, Lieberman D, et al.
Gastro Hep Adv . 2024 Aug; 1(1):55-62. PMID: 39129937
Background And Aims: Approximately 20%-30% of colorectal cancers (CRCs) arise from the serrated polyp pathway. CRC screening options have differential sensitivity to detect sessile serrated polyps (SSPs). We used the...
5.
Yoon J, Katcher E, Cohen E, Ward S, Rouphael C, Itzkowitz S, et al.
J Clin Gastroenterol . 2024 Jul; PMID: 39042489
Background: Gastric intestinal metaplasia (GIM) is a precancerous condition. Limited data exist on real-world clinical practice relative to guidelines. Aim: The aim of this study was to evaluate adherence to...
6.
Itzkowitz S, Jiang Y, Villagra C, Colombel J, Sultan K, Lukin D, et al.
Clin Gastroenterol Hepatol . 2024 May; PMID: 38768673
Background & Aims: In patients with inflammatory bowel disease (IBD) and a history of cancer, retrospective studies have suggested that exposure to immunosuppressive agents does not increase the risk of...
7.
Axelrad J, Hashash J, Itzkowitz S
Clin Gastroenterol Hepatol . 2024 May; 22(7):1365-1372. PMID: 38752967
Description: The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update (CPU) Commentary is to discuss the risks of various malignancies in patients with inflammatory bowel diseases (IBD)...
8.
Wijnands A, Penning de Vries B, Lutgens M, Bakhshi Z, Al Bakir I, Beaugerie L, et al.
Clin Gastroenterol Hepatol . 2024 Mar; 22(8):1697-1708. PMID: 38431223
Background & Aims: Colonoscopic surveillance is recommended in patients with colonic inflammatory bowel disease (IBD) given their increased risk of colorectal cancer (CRC). We aimed to develop and validate a...
9.
Harpaz N, Itzkowitz S
Gastroenterol Clin North Am . 2024 Jan; 53(1):133-154. PMID: 38280745
Timely diagnosis and effective management of colorectal dysplasia play a vital role in preventing mortality from colorectal cancer in patients with chronic inflammatory bowel disease. This review provides a contemporary...
10.
Zhou R, Harpaz N, Itzkowitz S, Parsons R
Oncogenesis . 2023 Oct; 12(1):48. PMID: 37884500
Sustained chronic inflammation of the large intestine leads to tissue damage and repair, which is associated with an increased incidence of colitis-associated colorectal cancer (CAC). The genetic makeup of CAC...